The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of BRAF mutations on outcomes in metastatic melanoma with central nervous system metastases treated with immune checkpoint inhibitors.
 
Hong De Sa
No Relationships to Disclose
 
Demitrios Dedousis
No Relationships to Disclose
 
Sree Harsha Tirumani
No Relationships to Disclose
 
Fatemeh Ardeshir-Larijani
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Loxo (Inst); Merck Serono (Inst); Merit, Inc. (Inst); Tesaro (Inst)
 
Ariel Ann Nelson
No Relationships to Disclose
 
Petra Martin
No Relationships to Disclose
 
Prateek Mendiratta
No Relationships to Disclose
 
Andrew E. Sloan
Stock and Other Ownership Interests - Surgical Theater
Honoraria - Monteris Medical
Consulting or Advisory Role - Monteris Medical
Research Funding - Merck (Inst)
Patents, Royalties, Other Intellectual Property - Radiosurgical Planning
 
Serah Choi
No Relationships to Disclose
 
David B. Mansur
No Relationships to Disclose
 
Jennifer Eva Selfridge
No Relationships to Disclose
 
Nikhil H. Ramaiya
No Relationships to Disclose
 
Christopher J. Hoimes
Honoraria - Seagen
Consulting or Advisory Role - 2bPrecise; Bristol-Myers Squibb; Eisai; Genentech/Roche; Merck Sharp & Dohme; Prometheus; Seagen
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Eisai; Genentech/Roche; Seagen
Research Funding - Merck Sharp & Dohme; Merck Sharp & Dohme (Inst)
(OPTIONAL) Uncompensated Relationships - 2bPrecise (Inst)